Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

The role of medical management for acute intravascular hemolysis in patients supported on axial flow LVAD.

Hasin T, Deo S, Maleszewski JJ, Topilsky Y, Edwards BS, Pereira NL, Stulak JM, Joyce L, Daly R, Kushwaha SS, Park SJ.

ASAIO J. 2014 Jan-Feb;60(1):9-14. doi: 10.1097/MAT.0000000000000012.

PMID:
24322715
2.

Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipients.

Whitson BA, Eckman P, Kamdar F, Lacey A, Shumway SJ, Liao KK, John R.

Ann Thorac Surg. 2014 Jun;97(6):2097-103. doi: 10.1016/j.athoracsur.2014.02.041.

PMID:
24775803
3.

Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.

Cowger JA, Romano MA, Shah P, Shah N, Mehta V, Haft JW, Aaronson KD, Pagani FD.

J Heart Lung Transplant. 2014 Jan;33(1):35-43. doi: 10.1016/j.healun.2013.08.021.

PMID:
24418732
4.

Incidence, Management, and Outcome of Suspected Continuous-Flow Left Ventricular Assist Device Thrombosis.

Upshaw JN, Kiernan MS, Morine KJ, Kapur NK, DeNofrio D.

ASAIO J. 2016 Jan-Feb;62(1):33-9. doi: 10.1097/MAT.0000000000000294.

PMID:
26479464
5.

Thrombolytic therapy for thrombosis of continuous flow ventricular assist devices.

Schlendorf K, Patel CB, Gehrig T, Kiefer TL, Felker GM, Hernandez AF, Blue LJ, Milano CA, Rogers JG.

J Card Fail. 2014 Feb;20(2):91-7. doi: 10.1016/j.cardfail.2013.12.011.

PMID:
24361803
6.

Left ventricular assist devices: an evidence-based analysis.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2004;4(3):1-69.

7.

Retrospective hemolysis comparison between patients with centrifugal biventricular assist and left ventricular assist devices.

Stepanenko A, Krabatsch T, Hennig E, Kaufmann F, Jurmann B, Dranishnikov N, Lehmkuhl HB, Pasic M, Weng Y, Hetzer R, Potapov EV.

ASAIO J. 2011 Sep-Oct;57(5):382-7. doi: 10.1097/MAT.0b013e31822c4994.

PMID:
21869615
8.

A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapy.

Katz JN, Jensen BC, Chang PP, Myers SL, Pagani FD, Kirklin JK.

J Heart Lung Transplant. 2015 May;34(5):701-9. doi: 10.1016/j.healun.2014.10.002.

PMID:
25582036
9.

What is the optimal anticoagulation in patients with a left ventricular assist device?

Rossi M, Serraino GF, Jiritano F, Renzulli A.

Interact Cardiovasc Thorac Surg. 2012 Oct;15(4):733-40. Review.

10.

Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.

John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):174-81. doi: 10.1016/j.jtcvs.2010.03.037.

11.

Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.

John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.

Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030.

PMID:
18805167
12.

Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation.

Stulak JM, Deo S, Schirger J, Aaronson KD, Park SJ, Joyce LD, Daly RC, Pagani FD.

Ann Thorac Surg. 2013 Dec;96(6):2161-7. doi: 10.1016/j.athoracsur.2013.07.004.

PMID:
24035302
13.
14.

Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.

Holman WL, Naftel DC, Eckert CE, Kormos RL, Goldstein DJ, Kirklin JK.

J Thorac Cardiovasc Surg. 2013 Aug;146(2):437-41.e1. doi: 10.1016/j.jtcvs.2013.02.018.

15.

Initial results of clinical trial with a new left ventricular assist device (LVAD) providing synchronous pulsatile flow.

Gazzoli F, Vigan├▓ M, Pagani F, Alloni A, Silvaggio G, Panzavolta M, El Banayosy A, Koerfer R, Morshuis M, Pavie A, Leprince P, Glauber M, Del Sarto P, Haxhademi D, Vitali E, Russo CF, Scuri S.

Int J Artif Organs. 2009 Jun;32(6):344-53.

PMID:
19670186
16.

Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.

Topkara VK, Kondareddy S, Malik F, Wang IW, Mann DL, Ewald GA, Moazami N.

Ann Thorac Surg. 2010 Oct;90(4):1270-7. doi: 10.1016/j.athoracsur.2010.04.093.

PMID:
20868826
17.

Thrombolysis for suspected intrapump thrombosis in patients with continuous flow centrifugal left ventricular assist device.

Muthiah K, Robson D, Macdonald PS, Keogh AM, Kotlyar E, Granger E, Dhital K, Spratt P, Jansz P, Hayward CS.

Artif Organs. 2013 Mar;37(3):313-8. doi: 10.1111/j.1525-1594.2012.01567.x.

PMID:
23373528
18.

Platelet activation in heart failure patients supported by the HeartMate II ventricular assist device.

Slaughter MS, Sobieski MA 2nd, Graham JD, Pappas PS, Tatooles AJ, Koenig SC.

Int J Artif Organs. 2011 Jun;34(6):461-8. doi: 10.5301/IJAO.2011.8459.

19.

End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.

Radovancevic B, Vrtovec B, de Kort E, Radovancevic R, Gregoric ID, Frazier OH.

J Heart Lung Transplant. 2007 Aug;26(8):815-8.

PMID:
17692785
20.

Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.

Boyle AJ, Jorde UP, Sun B, Park SJ, Milano CA, Frazier OH, Sundareswaran KS, Farrar DJ, Russell SD; HeartMate II Clinical Investigators..

J Am Coll Cardiol. 2014 Mar 11;63(9):880-8. doi: 10.1016/j.jacc.2013.08.1656.

Items per page

Supplemental Content

Support Center